Patient-centred management of Parkinson's disease – Authors' reply

Bloem, Bastiaan R.; Henderson, Emily; Dorsey, E. Ray; Okun, Michael S.; Okubadejo, Njideka; Chan, Piu; Andrejack, John; Darweesh, Sirwan K.L.; Munneke, Marten

doi:10.1016/s1474-4422(20)30360-4

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[22], we hypothesized that individuals who either have lost or are at risk of losing access to neurological care may similarly be at risk of losing access to primary care, and thus, vaccinations [23,24]. Fur- The team asked participants how many times they Table 2 shows the results for vaccination rates, healthcare utilization, and self-reported illnesses.…”

Section: Introductionmentioning

confidence: 99%

Barriers to Vaccination Among People with Parkinson’s Disease and Implications for COVID-19

Phanhdone

Drummond

Meisel

et al. 2021

JPD

View full text Add to dashboard Cite

Background: Patients with Parkinson’s disease (PD) are at higher risk of vaccine-preventable respiratory infections. However, advanced, homebound individuals may have less access to vaccinations. In light of COVID-19, understanding barriers to vaccination in PD may inform strategies to increase vaccine uptake. Objective: To identify influenza and pneumococcal vaccination rates, including barriers and facilitators to vaccination, among homebound and ambulatory individuals with PD and related disorders. Methods: Cross-sectional US-based study among individuals with PD, aged > 65 years, stratified as homebound or ambulatory. Participants completed semi-structured interviews on vaccination rates and barriers, and healthcare utilization. Results: Among 143 participants, 9.8% had missed all influenza vaccinations in the past 5 years, and 32.2% lacked any pneumococcal vaccination, with no between-group differences. Homebound participants (n = 41) reported difficulty traveling to clinic (p < 0.01) as a vaccination barrier, and despite similar outpatient visit frequencies, had more frequent emergency department visits (31.7% vs. 9.8%, p < 0.01) and hospitalizations (14.6% vs. 2.9%, p = 0.03). Vaccine hesitancy was reported in 35% of participants, vaccine refusal in 19%, and 13.3% reported unvaccinated household members, with no between-group differences. Nearly 13% thought providers recommended against vaccines for PD patients, and 31.5% were unsure of vaccine recommendations in PD. Conclusion: Among a sample of homebound and ambulatory people with PD, many lack age-appropriate immunizations despite ample healthcare utilization. Many participants were unsure whether healthcare providers recommend vaccinations for people with PD. In light of COVID-19, neurologist reinforcement that vaccinations are indicated, safe, and recommended may be beneficial.

show abstract

Section: Introductionmentioning

confidence: 99%